201 related articles for article (PubMed ID: 16248771)
1. Alpha-particle radioimmunotherapy of disseminated peritoneal disease using a (212)Pb-labeled radioimmunoconjugate targeting HER2.
Milenic DE; Garmestani K; Brady ED; Albert PS; Ma D; Abdulla A; Brechbiel MW
Cancer Biother Radiopharm; 2005 Oct; 20(5):557-68. PubMed ID: 16248771
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of high-LET radiation by gemcitabine: targeting HER2 with trastuzumab to treat disseminated peritoneal disease.
Milenic DE; Garmestani K; Brady ED; Albert PS; Abdulla A; Flynn J; Brechbiel MW
Clin Cancer Res; 2007 Mar; 13(6):1926-35. PubMed ID: 17363549
[TBL] [Abstract][Full Text] [Related]
3. Targeting of HER2 antigen for the treatment of disseminated peritoneal disease.
Milenic DE; Garmestani K; Brady ED; Albert PS; Ma D; Abdulla A; Brechbiel MW
Clin Cancer Res; 2004 Dec; 10(23):7834-41. PubMed ID: 15585615
[TBL] [Abstract][Full Text] [Related]
4. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
[TBL] [Abstract][Full Text] [Related]
5. Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212Pb.
Boudousq V; Bobyk L; Busson M; Garambois V; Jarlier M; Charalambatou P; Pèlegrin A; Paillas S; Chouin N; Quenet F; Maquaire P; Torgue J; Navarro-Teulon I; Pouget JP
PLoS One; 2013; 8(7):e69613. PubMed ID: 23922757
[TBL] [Abstract][Full Text] [Related]
6. (212)Pb-radioimmunotherapy induces G(2) cell-cycle arrest and delays DNA damage repair in tumor xenografts in a model for disseminated intraperitoneal disease.
Yong KJ; Milenic DE; Baidoo KE; Brechbiel MW
Mol Cancer Ther; 2012 Mar; 11(3):639-48. PubMed ID: 22238365
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of platinum chemotherapy in combination with HER2-targeted α-particle radiation.
Milenic DE; Baidoo KE; Shih JH; Wong KJ; Brechbiel MW
Cancer Biother Radiopharm; 2013; 28(6):441-9. PubMed ID: 23758610
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of Cell Killing Response from Low Linear Energy Transfer (LET) Radiation Originating from (177)Lu Radioimmunotherapy Targeting Disseminated Intraperitoneal Tumor Xenografts.
Yong KJ; Milenic DE; Baidoo KE; Brechbiel MW
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27196891
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunotherapy of human colon carcinoma xenografts using a 213Bi-labeled domain-deleted humanized monoclonal antibody.
Milenic D; Garmestani K; Dadachova E; Chappell L; Albert P; Hill D; Schlom J; Brechbiel M
Cancer Biother Radiopharm; 2004 Apr; 19(2):135-47. PubMed ID: 15186593
[TBL] [Abstract][Full Text] [Related]
10. Improved efficacy of alpha-particle-targeted radiation therapy: dual targeting of human epidermal growth factor receptor-2 and tumor-associated glycoprotein 72.
Milenic DE; Brady ED; Garmestani K; Albert PS; Abdulla A; Brechbiel MW
Cancer; 2010 Feb; 116(4 Suppl):1059-66. PubMed ID: 20127951
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunotherapy targeting of HER2/neu oncoprotein on ovarian tumor using lead-212-DOTA-AE1.
Horak E; Hartmann F; Garmestani K; Wu C; Brechbiel M; Gansow OA; Landolfi NF; Waldmann TA
J Nucl Med; 1997 Dec; 38(12):1944-50. PubMed ID: 9430475
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.
Hartmann F; Horak EM; Garmestani K; Wu C; Brechbiel MW; Kozak RW; Tso J; Kosteiny SA; Gansow OA; Nelson DL
Cancer Res; 1994 Aug; 54(16):4362-70. PubMed ID: 8044783
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of breast cancer cells overexpressing HER2/neu by 213Bi-Herceptin radioimmunoconjugate.
Zhang DY; Li Y; Rizvi SM; Qu C; Kearsley J; Allen BJ
Cancer Lett; 2005 Feb; 218(2):181-90. PubMed ID: 15670895
[TBL] [Abstract][Full Text] [Related]
14. Exploration of a F(ab')
Milenic DE; Kim YS; Baidoo KE; Wong KJ; Barkley R; Delgado J; Brechbiel MW
Cancer Biother Radiopharm; 2018 Jun; 33(5):182-193. PubMed ID: 29916748
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of Rhenium-188-labeled Herceptin on prostate cancer cell growth: a possible radioimmunotherapy to prostate carcinoma.
Wang HY; Lin WY; Chen MC; Lin T; Chao CH; Hsu FN; Lin E; Huang CY; Luo TY; Lin H
Int J Radiat Biol; 2013 May; 89(5):346-55. PubMed ID: 23294030
[TBL] [Abstract][Full Text] [Related]
16. Combined radioimmunotherapy and chemotherapy of breast tumors with Y-90-labeled anti-Her2 and anti-CEA antibodies with taxol.
Crow DM; Williams L; Colcher D; Wong JY; Raubitschek A; Shively JE
Bioconjug Chem; 2005; 16(5):1117-25. PubMed ID: 16173788
[TBL] [Abstract][Full Text] [Related]
17. Multimodality therapy: potentiation of high linear energy transfer radiation with paclitaxel for the treatment of disseminated peritoneal disease.
Milenic DE; Garmestani K; Brady ED; Baidoo KE; Albert PS; Wong KJ; Flynn J; Brechbiel MW
Clin Cancer Res; 2008 Aug; 14(16):5108-15. PubMed ID: 18698028
[TBL] [Abstract][Full Text] [Related]
18. The experimental study on the radioimmunotherapy of the nasopharyngeal carcinoma overexpressing HER2/neu in nude mice model with intratumoral injection of 188Re-herceptin.
Li G; Wang Y; Huang K; Zhang H; Peng W; Zhang C
Nucl Med Biol; 2005 Jan; 32(1):59-65. PubMed ID: 15691662
[TBL] [Abstract][Full Text] [Related]
19. Alpha-particle emitting atomic generator (Actinium-225)-labeled trastuzumab (herceptin) targeting of breast cancer spheroids: efficacy versus HER2/neu expression.
Ballangrud AM; Yang WH; Palm S; Enmon R; Borchardt PE; Pellegrini VA; McDevitt MR; Scheinberg DA; Sgouros G
Clin Cancer Res; 2004 Jul; 10(13):4489-97. PubMed ID: 15240541
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of 188Re-herceptin radioimmunotherapy in nude mouse model of nasopharyngeal carcinoma].
Li GP; Huang K; Zhang H
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr; 26(4):459-62. PubMed ID: 16624752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
